Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Nexar Capital Group acquires Ermitage Group

Tuesday, May 03, 2011

Ian Cadby
Nexar Capital Group SCA (Nexars), a global alternative investment manager, today announced the acquisition of Ermitage Limited (Ermitage), one of Europes pioneering alternative asset management organizations, from Caledonia Investments plc.

Founded in 1975, Ermitage has successfully served its long standing client base with a diverse offering of innovative investment solutions, which include customized hedge fund portfolios, multi and single manager hedge funds as well as wealth management services. Ermitage has also developed OPTICS, a highly advanced portfolio construction and risk management software tool.

Ian Cadby, Chief Executive Officer of Ermitage said, We are excited to be joining Nexars accomplished team and share their vision for building a premier alternative investment manager focused on alpha generation, risk management, transparency and innovation together with a strong institutional infrastructure. Over recent years, Ermitage has made significant advances as an innovative solutions provider, a specialist area we are now better placed to expand thanks to our combined resources and market reach.

Ermitages world class capabilities in delivering customized portfolios and services to sophisticated investors complements Nexars proven investment and risk management processes, said Eric Attias, Founding Partner and Chief Investment Officer of Nexar. Furthermore, Ermitages UK-based expertise and network will benefit Nexar's fund of hedge funds group located in New York and Paris.

Nexar Founding Partner and Chief Executive Officer Arie Assayag added, As Nexar continues to invest selectively in order to build a leading independent alternative investment platform, Ermitage represents a well regarded investment manager and a valuable addition. We are pleased to welcome Ermitages team to the Nexar Capital Group and we believe the synergies of Ermitage and Nexar will create a dynamic global group capable of meeting investors varied needs.

Source

Press Release
bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its